SHANGHAI, May 12, 2026 /PRNewswire/ --Insilico Medicine ("Insilico", 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has entered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results